Tonix Pharmaceuticals

Ticker

TNXP

Website

Sector

Healthcare

Tearsheet

Why Invest

Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is composed of immunology, central nervous system (CNS) and infectious disease product candidates.

  

  1. Assets continue to grow at more than 2x YoY, positive FCF should be coming soon.

  2. Aim to develop innovative therapies by focusing on unmet needs

  3. Has 1 phase three trials, and 5 phase 2 trials